as on January 27, 2026 at 8:07 pm IST
52 Week's Low
52 Week's High
5.21%
Downside
2.56%
Upside
Check Drugs Made In America Acquisition Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$307.8M
EPS (TTM)
0Dividend Yield
0.00%
PE Ratio (TTM)
0PEG Ratio
0Return On Equity TTM
0.00%
Compare market cap, revenue, PE, and other key metrics of Drugs Made In America Acquisition Corp with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $307.8M | NA | NA | 0.00% | |
| NA | $2.8B | NA | NA | 0.00% | |
| NA | $4.0B | NA | 24.08 | 0.00% |
The Drugs Made In America Acquisition Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Drugs Made In America Acquisition Corp investment value today
Current value as on today
₹1,11,474
Returns
₹11,474
(+11.47%)
Returns from Drugs Made In America Acquisition Corp Stock
₹5,500 (+5.5%)
Dollar Returns*
₹5,974 (+5.97%)
Search interest for Drugs Made In America Acquisition Corp Stock has increased by 100% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:100% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, DMAAU stock has moved up by 0.5%
| Organisation | Drugs Made In America Acquisition Corp |
| Headquarters | 1 East Broward Boulevard, Fort Lauderdale, FL, United States, 33301 |
| CEO | Ms. Lynn Stockwell |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Lynn Stockwell | CEO & Executive Chairman |
Mr. Saleem Elmasri CPA | CFO & Principal Accounting Officer |
Drugs Made In America Acquisition Corp share price today is $10.55 as on . Drugs Made In America Acquisition Corp share today touched a day high of $10.55 and a low of $10.55.
Drugs Made In America Acquisition Corp share touched a 52 week high of $10.82 on and a 52 week low of $10 on . Drugs Made In America Acquisition Corp stock price today i.e. is trending at $10.55,which is 2.50% down from its 52 week high and 5.50% up from its 52 week low.
Drugs Made In America Acquisition Corp market capitalisation is $0.00T as on .
Indian investors can start investing in Drugs Made In America Acquisition Corp (DMAAU) shares with as little as ₹91.762 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹917.62 in Drugs Made In America Acquisition Corp stock (as per the Rupee-Dollar exchange rate as on ).
Based on Drugs Made In America Acquisition Corp share’s latest price of $10.55 as on January 27, 2026 at 8:07 pm IST, you will get 0.9479 shares of Drugs Made In America Acquisition Corp. Learn more about
fractional shares .